02/03/2025
6:39 PM | JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:39 PM | Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:39 PM | Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:40 PM | Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:40 PM | McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:17 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:40 PM | Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:42 PM | Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:42 PM | JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:42 PM | McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:43 PM | Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for XERS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
11/26/2024
4:00 PM | Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:13 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:15 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
5:28 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:27 PM | Xeris Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2024
6:15 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
4:22 PM | McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
4:22 PM | Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:14 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:15 PM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:18 PM | HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:18 PM | Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:18 PM | PERSKY MARLA (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:18 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:19 PM | BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:19 PM | SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:19 PM | Fairley Ricki Louise (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:19 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:19 PM | Xeris Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:14 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:32 PM | Xeris Biopharma (Filer)
| Form ARS | |
04/23/2024
3:24 PM | Xeris Biopharma (Filer)
| Form DEF 14A | |
04/23/2024
3:26 PM | Xeris Biopharma (Filer)
| Form DEFA14A | |
04/11/2024
3:05 PM | SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:43 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:45 PM | Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:32 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:03 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:19 PM | Xeris Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
6:27 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal…
A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology.
It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here. |
Free XERS Stock Alerts